Ovarian Cancer Clinical Trials

Showing 361-380 of 902 trials

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

NCT05363605

This first-in-human study evaluates safety, tolerability and distribution of \[225Ac\] FPI-1966, \[111In\]-FPI-1967, and vofatamab in patients with FGFR3-expressing solid tumors.

Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more

Fusion Pharmaceuticals Inc.6 participantsStarted Apr 2022

Duarte, California, United States • San Francisco, California, United States • Iowa City, Iowa, United States +3 more locations

UNKNOWN

Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

NCT04675320

This study concerns the creation of a biological collection (blood samples) in patients with Epithelial Ovarian Cancer in in order to describe the immune response with PARP inhibitors.

Ovarian Cancer

Centre Georges Francois Leclerc50 participantsStarted Jul 2020

Besançon, France • Dijon, France

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

Related Searches

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer

Sirius in Gynaecological Laparoscopic Surgery

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study

Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer

BrUOG 390: Neoadjuvant Treatment With Talazoparib

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action